Stem cell therapy for vascular disease

被引:35
作者
Adams, Benjamin [1 ]
Xiao, Qingzhong [1 ]
Xu, Qingbo [1 ]
机构
[1] Kings Coll London, Div Cardiovasc, James Black Ctr, London SE5 9NU, England
关键词
D O I
10.1016/j.tcm.2007.08.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Endothelial dysfunction/loss is a key event in the development of vascular diseases, including native atherosclerosis, angioplasty-induced restenosis, transplant arteriosclerosis, and vein bypass graft atherosclerosis. in challenge to the traditional concept that lost endothelial cells were replaced by neighboring endothelial replication, recent studies have shown that stem cells in blood and the vessel wall have the ability to repair endothelial cells after extensive loss. Concomitantly, accumulating data indicate that stem cell therapy is a promising option for the treatment of vascular diseases and might, in the future, contribute to tissue regeneration, that is, the restoration of endothelium lining the arteries to recover the function of the vascular system. In the present review, we will focus on the progress of stem cell therapy, discuss the mechanisms of stem cell differentiation into endothelial cells, and point out the clinical potential of stem cell therapy in the future. (Trends Cardiovasc Med 2007; 17:246-251) (c) 2007, Elsevier Inc.
引用
收藏
页码:246 / 251
页数:6
相关论文
共 42 条
  • [1] Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia
    Aicher, Alexandra
    Rentsch, Markus
    Sasaki, Ken-ichiro
    Ellwart, Joachim W.
    Faendrich, Fred
    Siebert, Reiner
    Cooke, John P.
    Dimmeler, Stefanie
    Heeschen, Christopher
    [J]. CIRCULATION RESEARCH, 2007, 100 (04) : 581 - 589
  • [2] Concise review: Stem cells, myocardial regeneration, and methodological artifacts
    Anversa, Piero
    Leri, Annarosa
    Rota, Marcello
    Hosoda, Toru
    Bearzi, Claudia
    Urbanek, Konrad
    Kajstura, Jan
    Bolli, Roberto
    [J]. STEM CELLS, 2007, 25 (03) : 589 - 601
  • [3] Intracoronary infusion of progenitor cells is not associated with aggravated restenosis development or atherosclerotic disease progression in patients with acute myocardial infarction
    Assmus, Birgit
    Walter, Dirk H.
    Lehmann, Ralf
    Honold, Joerg
    Martin, Hans
    Dimmeler, Stefanie
    Zeiher, Andreas M.
    Schaechinger, Volker
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 (24) : 2989 - 2995
  • [4] Development of tissue engineered vascular grafts
    Campbell, G. R.
    Campbell, J. H.
    [J]. CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2007, 8 (01) : 43 - 50
  • [5] Gray B H, 1996, Vasc Med, V1, P287
  • [6] Tissue-engineered blood vessels - Alternative to autologous grafts?
    Hoenig, MR
    Campbell, GR
    Rolfe, BE
    Campbell, JH
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (06) : 1128 - 1134
  • [7] Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice
    Hu, YH
    Zhang, ZY
    Torsney, E
    Afzal, AR
    Davison, F
    Metzler, B
    Xu, QB
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (09) : 1258 - 1265
  • [8] Smooth muscle cells in transplant atherosclerotic lesions are originated from recipients, but not bone marrow progenitor cells
    Hu, YH
    Davison, F
    Ludewig, B
    Erdel, M
    Mayr, M
    Url, M
    Dietrich, H
    Xu, QB
    [J]. CIRCULATION, 2002, 106 (14) : 1834 - 1839
  • [9] Endothelial replacement and angiogenesis in arteriosclerotic lesions of allografts are contributed by circulating progenitor cells
    Hu, YH
    Davison, F
    Zhang, ZY
    Xu, QB
    [J]. CIRCULATION, 2003, 108 (25) : 3122 - 3127
  • [10] Epigenetic histone modification and cardiovascular lineage programming in mouse embryonic stem cells exposed to laminar shear stress
    Illi, B
    Scopece, A
    Nanni, S
    Farsetti, A
    Morgante, L
    Biglioli, P
    Capogrossi, MC
    Gaetano, C
    [J]. CIRCULATION RESEARCH, 2005, 96 (05) : 501 - 508